The long-term objective is to understand the modulating effect of types of dietary fat differing in fatty acid composition on colon cancer. Specifically, it is proposed to study the mechanism(s) of types and amount of fat namely corn oil (CO) and menhaden fish oil (FO) on colon carcinogenesis. Azoxymethane (AOM), an aliphatic azoxy compound will be used to induce colon tumors. The effect of types and amount of dietary fat on the relevant biochemical parameters that are associated with colon tumor promotion will be determined and will include cecal bacterial 7alpha-dehydroxylase and phospholipase C activities, fecal diglycerides and bile acids, and colonic mucosal and tumor, 1,2-diacylglycerol, phospholipase C, DAG kinase, protein kinase C, prostaglandin synthesis, arachidonic acid metabolism via cyclooxygenase pathway, and ras p21. At 5 weeks of age, male F344 rats will be fed low-fat AIN-76A diet. At 7 weeks of age, groups of rats will be treated with two weekly s.c. doses of AOM or normal saline (vehicle) and transferred to high fat diets containing CO or FO diet. Then, day at 1 and week 1 and 12 following AOM treatment and at termination (wk 42), the above biochemical parameters will be measured in colon mucosa and tumors (at termination) to elucidate the mechanistic role of types and amount in colon carcinogenesis. Also, during the weeks of 4 and 12 on experimental diets and at termination, groups of animals from each dietary group treated with AOM will be sacrificed and cecal bacterial 7alpha-dehydroxylase and phospholipase C and fecal bile acids and diglycerides will be determined. Biochemical and physiological parameters of various dietary groups will be analyzed statistically to determine the significance of difference. The selected biochemical parameters taken together would suggest the possible mechanism of in vivo tumor promotion or inhibition by types of dietary fat.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA037663-08
Application #
2089416
Study Section
Metabolic Pathology Study Section (MEP)
Project Start
1993-09-30
Project End
1996-09-29
Budget Start
1994-09-30
Budget End
1995-09-29
Support Year
8
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Institute for Cancer Prevention
Department
Type
DUNS #
City
Valhalla
State
NY
Country
United States
Zip Code
10595
Liu, Yingying; Ju, Jihyeung; Xiao, Hang et al. (2008) Effects of combination of calcium and aspirin on azoxymethane-induced aberrant crypt foci formation in the colons of mice and rats. Nutr Cancer 60:660-5
Xiao, Hang; Zhang, Qiang; Lin, Yong et al. (2008) Combination of atorvastatin and celecoxib synergistically induces cell cycle arrest and apoptosis in colon cancer cells. Int J Cancer 122:2115-24
Kelly, Karen; Chansky, Kari; Gaspar, Laurie E et al. (2008) Phase III trial of maintenance gefitinib or placebo after concurrent chemoradiotherapy and docetaxel consolidation in inoperable stage III non-small-cell lung cancer: SWOG S0023. J Clin Oncol 26:2450-6
Reddy, Bandaru S (2007) Strategies for colon cancer prevention: combination of chemopreventive agents. Subcell Biochem 42:213-25
Reddy, Bandaru S; Wang, Chung Xiou; Kong, Ah-Ng et al. (2006) Prevention of azoxymethane-induced colon cancer by combination of low doses of atorvastatin, aspirin, and celecoxib in F 344 rats. Cancer Res 66:4542-6
Reddy, Bandaru S; Rao, Chinthalapally V (2005) Chemoprophylaxis of colon cancer. Curr Gastroenterol Rep 7:389-95
Reddy, Bandaru S (2004) Studies with the azoxymethane-rat preclinical model for assessing colon tumor development and chemoprevention. Environ Mol Mutagen 44:26-35
Narayanan, Bhagavathi A; Narayanan, Narayanan K; Desai, Dhimant et al. (2004) Effects of a combination of docosahexaenoic acid and 1,4-phenylene bis(methylene) selenocyanate on cyclooxygenase 2, inducible nitric oxide synthase and beta-catenin pathways in colon cancer cells. Carcinogenesis 25:2443-9
Swamy, Malisetty V; Cooma, Indranie; Patlolla, Jagan M R et al. (2004) Modulation of cyclooxygenase-2 activities by the combined action of celecoxib and decosahexaenoic acid: novel strategies for colon cancer prevention and treatment. Mol Cancer Ther 3:215-21
Reddy, Bandaru S (2004) Omega-3 fatty acids in colorectal cancer prevention. Int J Cancer 112:1-7

Showing the most recent 10 out of 48 publications